OPTOSURGICAL, LLC
SBIR award from Department of the Interior.
Summary
Optosurgical, LLC won about $2.1 million in SBIR Phase II funding to turn a new contrast agent into a practical tool. The agent targets the biliary tract to make image-guided liver and bile-duct procedures safer and more successful.
- Amount
- $2,095,748
- Agency
- Department of the Interior · Departmental Offices
- Program / Phase
- SBIR
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- MD
- Period
- 2026-04-08 → 2029-01-09
Technology domains
Human Performance & Medical
Description
SBIR PH II "TRANSLATION OF NOVEL BILIARY TRACT-SPECIFIC CONTRAST AGENT TO MEDIATE SUCCESSFUL IMAGE-GUIDED HEPATOBILIARY INTERVENTIONS"